Journey Medical (DERM) Interest Expenses (2020 - 2026)
Journey Medical's (DERM) quarterly Interest Expenses came in at $3.2 million in Q1 2026, up 21.73% YoY from $2.6 million in Q1 2025, and up 284.77% on a QoQ basis from $821000.0 in Q4 2025.
Journey Medical (DERM) Interest Expenses (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Interest Expenses data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Interest Expenses rose 21.73% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 21.73% YoY) and the FY2025 annual result came in at $26.0 million, down 99.58% from the prior year.
- Interest Expenses rose to $3.2 million in Q1 2026, from $821000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $14.7 million in Q2 2025 to a low of -$685000.0 in Q4 2023.
- A 5-year average of $3.9 million and a median of $2.6 million in 2025 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses slumped 211.02% — and 2024, when it soared 507.87%.
- Tracing DERM's Interest Expenses over 5 years: stood at $617000.0 in 2022, then tumbled by 211.02% to -$685000.0 in 2023, then surged by 207.59% to $737000.0 in 2024, then grew by 11.4% to $821000.0 in 2025, then soared by 284.77% to $3.2 million in 2026.
- The last three Interest Expenses figures came in at $3.2 million (Q1 2026), $821000.0 (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Journey Medical | 202.90 Mn | 177.26 Mn | 12.37 Mn | 906,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91 Mn |
| Jun 30, 2026 | 5.91 Mn |
| Mar 31, 2026 | 3.16 Mn |
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 821,000.00 |
| Dec 31, 2025 | 821,000.00 |
| Sep 30, 2025 | 5.54 Mn |
| Sep 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 14.67 Mn |
| Jun 30, 2025 | 14.67 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 737,000.00 |
| Dec 31, 2024 | 737,000.00 |
| Sep 30, 2024 | 10.64 Mn |
| Sep 30, 2024 | 10.64 Mn |
| Jun 30, 2024 | 10.79 Mn |
| Jun 30, 2024 | 10.79 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.60 Mn |